Position in CELC
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$52,169,969
-$2,352,004 QoQ
Shares Held
457,070
-16.4% QoQ
Ownership
0.937%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 89.43706653247861.ToString("F0")%
Shared 0.ToString("F0")%
None 10.562933467521386.ToString("F0")%
Common Shares in CELC Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Artisan Partners Limited Partnership holds $3,601,883,777 across 24 Biotechnology names. CELC ranks #6 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
1,467,982 | $1,071,993,855 | |
| 2 | INSM |
INSMED Inc
|
6,527,301 | $1,067,344,259 | |
| 3 | ASND |
Ascendis Pharma A/S
|
3,230,188 | $738,840,901 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
2,058,308 | $154,558,347 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
183,540 | $96,077,683 | |
| 6 | CELC |
Celcuity Inc.
This page
|
457,070 | $52,169,969 | |
| 7 | DBVT |
DBV Technologies S.A.
|
2,219,386 | $46,362,973 | |
| 8 | LEGN |
Legend Biotech Corp
|
2,254,488 | $40,783,687 |
All Filings in CELC
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $52,169,969 | 457,070 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $54,521,973 | 546,641 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $28,943,064 | 585,892 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $5,362,401 | 401,678 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $4,596,471 | 454,646 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,433,826 | 491,507 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $6,197,744 | 415,677 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $7,091,196 | 432,918 | Shares | Sole | 2024-08-12 | |
| No filing history on record for this holder in this stock. | ||||||